A pragmatic trial of e-cigarettes, incentives, and drugs for smoking cessation

New England Journal of Medicine

Volumn 378, Issue 24, 2018, Pages 2302-2310

  Halpern, Scott D ^a,b,c,d,e   Harhay, Michael O ^c,d,e,g   Saulsgive, Kathryn ^c,d   Brophy, Christine ^h   Troxel, Andrea B ^d,i   Volp, Kevin G ^a,b,d,f,g  

^a Departments of Medicine   (United States)

^b Medical Ethics and Health Policy   (United States)

^c Center for Clinical Epidemiology and Biostatistics   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e Palliative and Advanced Illness Research Center   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h Vitality Institute   (United States)

ⁱ NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ELECTRONIC CIGARETTE; FEMALE; HEALTH HAZARD; HUMAN; MALE; MEDICAL INFORMATION; MOTIVATION; NICOTINE REPLACEMENT THERAPY; PERSONNEL MANAGEMENT; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; STANDARDIZATION; TEXT MESSAGING; TREATMENT DURATION; CLINICAL TRIAL; COMPARATIVE STUDY; ECONOMICS; HEALTH PROMOTION; MIDDLE AGED; MULTICENTER STUDY; OCCUPATIONAL HEALTH SERVICE; PROCEDURES; PSYCHOLOGY; REWARD; TREATMENT OUTCOME;

ADULT; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; MOTIVATION; OCCUPATIONAL HEALTH SERVICES; REWARD; SMOKING; SMOKING CESSATION; TEXT MESSAGING; TREATMENT OUTCOME;

EID: 85048766086     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsa1715757     Document Type: Article

References (27)

1. Willis Towers Watson. Full report: 2016 21st annual Willis Towers Watson Best Practices in Health Care Employer Survey-high-performance insights. January 4, 2017 (https://www .willistowerswatson .com/en/insights/2017/01/full-report-2016-21st-Annual-willis-Towers-watson-best-practices-in-health-care-employer-survey).
2. Rostron BL, Chang CM, Pechacek TF. Estimation of cigarette smoking-Attributable morbidity in the United States. JAMA Intern Med 2014; 174: 1922-8.
3. Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009; 6(4): e1000058.
4. Berman M, Crane R, Seiber E, Munur M. Estimating the cost of a smoking employee. Tob Control 2014; 23: 428-33.
5. Volpp KG, Troxel AB, Pauly MV, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009; 360: 699-709.
6. Halpern SD, French B, Small DS, et al. Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med 2015; 372: 2108-17.
7. Kahneman D, Tversky A. Prospect theory: An analysis of decision under risk. conometrica 1979; 47: 263-91.
8. Halpern SD, Asch DA, Volpp KG. Commitment contracts as a way to health. BMJ 2012; 344: e522.
9. Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ 2015; 350: h2147.
10. Kullgren JT, Troxel AB, Loewenstein G, et al. Individual-versus group-based financial incentives for weight loss: A randomized, controlled trial. Ann Intern Med 2013; 158: 505-14.
11. Asch DA, Troxel AB, Stewart WF, et al. Effect of financial incentives to physicians, patients, or both on lipid levels: A randomized clinical trial. JAMA 2015; 314: 1926-35.
12. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003; 5: 13-25.
13. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005; 100: 299-303.
14. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002; 4: 149-59.
15. Jacob P, Hatsukami D, Severson H, Hall S, Yu L, Benowitz NL. Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 2002; 11: 1668-73.
16. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst Abuse 2013; 7: 139-46.
17. van Staden SR, Groenewald M, Engelbrecht R, Becker PJ, Hazelhurst LT. Carboxyhaemoglobin levels, health and lifestyle perceptions in smokers converting from tobacco cigarettes to electronic cigarettes. S Afr Med J 2013; 103: 865-8.
18. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6: 65-70.
19. Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. Cochrane Database Syst Rev 2015; 5: CD004307.
20. Asay GRB, Homa DM, Abramsohn EM, Xu X, O'Connor EL, Wang G. Reducing smoking in the US federal workforce: 5-year health and economic impacts from improved cardiovascular disease outcomes. Public Health Rep 2017; 132: 646-53.
21. Schult TM, Kelly Q, Schmunk SK, Awosika ER. From policy to practice: Tobacco use cessation for employees in the Veterans Health Administration. J Occup Environ Med 2016; 58: 525-31.
22. Huang H, Mattke S, Batorsky B, Miles J, Liu H, Taylor E. Incentives, program configuration, and employee uptake of workplace wellness programs. J Occup Environ Med 2016; 58: 30-4.
23. Fairchild AL, Sung Lee J, Bayer R, Curran J. E-cigarettes and the harm-reduction continuum. N Engl J Med 2018; 378: 216-9.
24. National Academies of Sciences, Engineering, and Medicine. Public health consequences of e-cigarettes. Washington, DC: National Academies Press, 2018.
25. Halpern SD, French B, Small DS, et al. Heterogeneity in the effects of rewardand deposit-based financial incentives on smoking cessation. Am J Respir Crit Care Med 2016; 194: 981-8.
26. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: A randomised controlled trial. Lancet 2013; 382: 1629-37.
27. Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: A prospective 12-month randomized control design study. PLoS One 2013; 8(6): e66317.